Page 13 - Envision November-December 2020

KIDS

SHOULD

GROW

STRONGER

Their myopia shouldn’t.

CLINICALLY

PROVEN

Now you can help slow the progression of myopia in your young patients.
1
®
™
Introducing the Brilliant Futures Myopia Management Program with MiSight 1 day contact lenses.
MiSight 1 day is the first and only FDA-approved soft contact lens to slow the progression of myopia
*
®
in children aged 8-12 at the initiation of treatment.
1†
59 % 52 %

Slows Myopia Progression Axial Length Child Friendly 1
on average 1† Elongation Reduction 1 day lens
on average 1†

Ask your CooperVision sales Territory Manager about Brilliant Futures with MiSight 1 day,
™
®
or visit coopervision.ca/practitioner/myopia-management to learn more.

*USA Indications for Use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in
children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters(spherical equivalent) with ≤ 0.75 diopters of astigmatism. The
lens is to be discarded after each removal. Canadian Indications for Use: MiSight (omafilcon A) Soft Contact Lenses for Myopia Control may reduce the rate of myopia progression in children (6-18) and
correct ametropia. Reduction of myopia progression was observed in children with wearing time of 12 hours (8-16 hours) per day, 6.4 days (5-7) per week in a clinical study. Permanent myopia control
after lens treatment is discontinued is not supported by clinical studies. MiSight (omafilcon A) Soft Contact Lenses for Myopia Control are indicated for single use daily disposable wear. When prescribed for
daily disposable wear, the lens is to be discarded after each removal. †Compared to a single vision 1 day lens over a 3 year period. 1. Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for
myopia control. Optom Vis Sci. 2019; 96(8):556-567.